Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
RXRX
ACCE ResearchedRecursion Pharmaceuticals Inc. Class A Common Stock
HealthcareBiotechnologyNASDAQ
$3.39
-2.02%today
MKT CAP
$1.8B
NEXT EARNINGS
May 6
Analysis in progress.
-28.8% · 1Y
Get the ACCE weekly digest
Index returns, picks recap, score movers — every Sunday. No fluff.